Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris

Wang  Zhong-liang; Qian Shi-ming; Zhang Han-mei

doi:10.1007/s11655-001-0301-z

Your Location：

Home >

Browse articles >

Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris

OriginalPaper | Updated：2021-08-27

- Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris
- Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris
- 中国结合医学杂志（英文版） 2006年12卷第4期页码：301-305
- Affiliations：
  
  1. Department of Cardiopathy, TCM Hospital of Xuzhou City,Jiangsu,China
  2. Nanjing University of TCM,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-001-0301-z
  中图分类号：
- 纸质出版日期：2006，
Scan for full text
Wang, Zl., Qian, Sm. & Zhang, Hm. Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris., Chin. J Integ. Med. 12, 301–305 (2006). https://doi.org/10.1007/s11655-001-0301-z

Wang Zhong-liang, Qian Shi-ming, Zhang Han-mei. Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris[J]. Chinese Journal of Integrative Medicine, 2006,12(4):301-305.
Wang, Zl., Qian, Sm. & Zhang, Hm. Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris., Chin. J Integ. Med. 12, 301–305 (2006). https://doi.org/10.1007/s11655-001-0301-z DOI：

Wang Zhong-liang, Qian Shi-ming, Zhang Han-mei. Effect of Xin’ anning Nasal Drop (心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris[J]. Chinese Journal of Integrative Medicine, 2006,12(4):301-305. DOI： 10.1007/s11655-001-0301-z.

摘要

To observe the clinical efficacy of Xin’ anning Nasal Drop (XAND

心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris (CHD-UAP). Sixty patients with CHD-UAP were assigned

according to the randomizing number table

to two groups

the control group treated with conventional Western medicine

and the treated group treated with conventional Western medicine plus XAND. The clinical efficacy and the changes of S-T segment in resting EKG and total ischemia burden (TIB) in 24-h dynamic EKG were observed. The clinical efficacy

including the effect of angina alleviation

its initiation

and the effect of TCM syndrome score reduction

were significantly superior in the treated group to those in the control group (P<0.05 or P<0.01). The degree and extent of myocardial ischemia were significantly improved in both groups (P<0.01)

but the improvement in the treated group was better than that in the control group (P<0.05). Moreover

it was worth mentioning that the immediate effect in the treated group was better than that in the control group

and the reduction of TIB

the improvement in heart rate and myocardial oxygen consumption (immediately after the first administration or by the end of the therapeutic course)

and systolic blood pressure after treatment in the former were all superior to those in the latter

showing significant difference (P<0.05 or P<0.01). XAND has a quick effect in alleviating angina in patients with CHD-UAP

and it is worthy of furtherstudies and spreading in clinical practice.

Abstract

To observe the clinical efficacy of Xin’ anning Nasal Drop (XAND

心安宁滴鼻剂) in treating coronary heart disease with unstable angina pectoris (CHD-UAP). Sixty patients with CHD-UAP were assigned

according to the randomizing number table

to two groups

the control group treated with conventional Western medicine

including the effect of angina alleviation

its initiation

and the effect of TCM syndrome score reduction

were significantly superior in the treated group to those in the control group (P<0.05 or P<0.01). The degree and extent of myocardial ischemia were significantly improved in both groups (P<0.01)

but the improvement in the treated group was better than that in the control group (P<0.05). Moreover

it was worth mentioning that the immediate effect in the treated group was better than that in the control group

and the reduction of TIB

the improvement in heart rate and myocardial oxygen consumption (immediately after the first administration or by the end of the therapeutic course)

and systolic blood pressure after treatment in the former were all superior to those in the latter

showing significant difference (P<0.05 or P<0.01). XAND has a quick effect in alleviating angina in patients with CHD-UAP

and it is worthy of furtherstudies and spreading in clinical practice.

关键词

unstable angina pectorisXin’ anning Nasal DropClinical Study

Keywords

unstable angina pectorisXin’ anning Nasal DropClinical Study

references

Branch Angiocardiopathy, Chinese Medical Association and Editorial Board of Chinese Journal of Cardiology. Diagnosis and Treatment Recommendation of Unstable Angina Pectoris. Chin J Cardiovasc Dis 2000;28(6): 409–412.

Chen KJ, Liao JZ, Xiao ZX, et al., editors. Studies on cardio-cerebral vascular diseases. Shanghai: Shanghai Scientific and Technical Publishers, 1988: 311–313.

Department of Medical Administration, State Administration of Traditional Chinese Medicine. Norm of diagnosis and treatment of internal emergent diseases by TCM. Nanjing: Nanjing University Press, 1994: 45–55.

Fan LL, DD.O’ Keefe, WJ Powell, et al. Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Acta Pharm Sin 1984;19(11): 801–804.

Liu QG, Wang L, Lu ZY, et al. The protective effect of puerarin on ischemic myocardium in dogs and its possible mechanism. J Clin Cardiol 1998;14(5): 292–295.

Lu XR, Chen SM, Sun T. Study of β-adrenergic receptor blocking effect of extractum of root pueraria pseudo-hisuta. Acta Pharm Sin 1980;15(4): 218–220.

Yang JY. Study on the anti-arrhythmia effect of Radix Puerariae. Chin Mod J Pharmacol 1998;9(2): 53–55.

Wang YM. Clinical study on microcirculation. Clin Med Chin 1998;14(2): 121–123.

Shen ZF and Xie MZ. Hypoglycemic effect of the combined use of puerarin and aspirin in mice. Acta Pharmac Sin 1985;20(11): 863–864.

Wang YS, editor. Pharmacology and application of Chinese materia medica. Beijnig: People’ s Medical Publishing House, 1983: 1136.

Huang ZH, Jin ZJ, He GX. Effects of puerarin on arterial endothelial cells of calves. Chin J Gerontol 1992;12(6): 350–351.

Zhang GC, Fang SM. Antioxidation of pueraria lobata isoflavones. Acta Univ Med Tongji 1997;26(5): 340–341.

Wang KZ, Lu HX, Diao WX, et al. Protective effect of Radix Codonopsis on experimental acute myocardial ischemia. Chin Tradit Herbal Drugs 1989;20(2): 29–31.

Liu GZ, Zhou JH. Progress of study on chemical composition and pharmacological effect of Radix Codonopsis. Chin J Integr Tradit West Med 1983;3(2): 114–116.

Wang KZ, Lu HX, Diao WX, et al. Effect of Tangshen on microcirculatory disturbance. J Shandong Univ Tradit Chin Med 1989;13(3): 48–49.

Huang EM, Liu SH, Peng YF, et al. Effects of ginseng, asiabell root and licorice root on late stage of hemorrhagic shock in rabbits. Hubei J Tradit Chin Med 1984;6(6): 51–52.

Wang YM. Preliminary observation on the hypotensive effect of some Chinese drugs. Shanghai J Tradit Chin Med 1956;(1): 36–41.

Wang SR, Xu X, Lu XY, et al. Study on the activating action of different extracts from asiabell root. J Beijing Univ Chin Med 1993;16(5): 60–62.

Chen JW, Xu YM, Wang YS, et al. Analysis on the composition of amino acid in cultivated and wild Radix Changii produced in Jiangsu Province. J Nanjing Univ Tradit Chin Med 1993;9(2): 26–27.

FULL TEXT LINK

More>

浏览量

363

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effect of Xuefu Zhuyu pill on platelet activating factor expression in patients with unstable angina pectoris

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

Oral herbal medicines for psoriasis: A review of clinical studies

Alleviation of cancerous pain by external compress with Xiaozheng Zhitong Paste (消癥止痛方)

Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema